Development of photocrosslinked sialic acid containing polymers for use in Aβ toxicity attenuation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Glycosylation and Glycoproteins Research · Alzheimer's disease research and treatments · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Attenuation of beta-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers10.1016/j.bbagen.2006.08.008 ↗
2. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset10.2105/AJPH.88.9.1337 ↗
3. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss10.1073/pnas.1834302100 ↗
4. A model for beta-amyloid aggregation and neurotoxicity based on the free radical generating capacity of the peptide: implications of “molecular shrapnel” for Alzheimer's disease
5. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide10.1042/bj3480137 ↗
6. Inhibition of toxicity and protofibril formation in the amyloid-beta peptide beta(25–35) using N-methylated derivatives10.1042/bst0300537 ↗
7. The interaction between Alzheimer amyloid beta(1–40) peptide and ganglioside GM1-containing membranes10.1016/S0014-5793(96)01504-9 ↗
8. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum10.1073/pnas.90.2.567 ↗
9. Interaction between amyloid beta-protein aggregates and membranes10.1002/psc.570 ↗
10. Neuropathology of Alzheimer's disease10.1016/j.nic.2005.09.003 ↗
11. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta10.1073/pnas.1237107100 ↗
12. Development of a novel diffusion-based method to estimate the size of the aggregated abeta species responsible for neurotoxicity10.1002/bit.10347 ↗
13. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases10.1074/jbc.C400260200 ↗
14. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability10.1074/jbc.M201750200 ↗
15. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E10.1006/bbrc.1994.1209 ↗
16. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure10.1085/jgp.200609533 ↗
17. Cellular cholesterol efflux mediated by cyclodextrins10.1074/jbc.270.29.17250 ↗
18. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1–40)] in bilayer membranes10.1073/pnas.90.22.10573 ↗
19. Histidines 13 and 14 in the Abeta sequence are targets for inhibition of Alzheimer's disease Abeta ion channel and cytotoxicity10.4067/S0716-97602006000300007 ↗
20. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists10.3233/JAD-2002-4309 ↗
21. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity10.1006/jsbi.2000.4274 ↗
22. Characterization of high-affinity binding between gangliosides and amyloid beta-protein10.1006/abbi.2001.2304 ↗
23. GM1 inhibits amyloid beta-protein-induced cytokine release10.1023/A:1022557920150 ↗
24. Interactions of amyloid beta-peptide (1–40) with ganglioside-containing membranes10.1021/bi982345o ↗
25. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes10.1016/j.bbrc.2005.01.060 ↗
26. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease10.1038/nm1095-1062 ↗
27. GM1 ganglioside regulates the proteolysis of amyloid precursor protein10.1038/sj.mp.4001509 ↗
28. Gangliosides inhibit the release of interleukin-1beta in amyloid beta-protein-treated human monocytic cells10.1385/JMN:17:3:371 ↗
29. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid10.1021/bi0255874 ↗
30. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid10.1074/jbc.M100252200 ↗
31. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds10.1002/bit.10605 ↗
32. Adaptation of the periodate–resorcinol method for determination of sialic acids to a microassay using microtiter plate reader10.1006/abio.1993.1445 ↗
33. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M ↗
34. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers10.1021/bc980099n ↗
35. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers10.1086/344316 ↗
36. Attenuation of beta-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment10.1016/j.brainres.2007.05.055 ↗
37. Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer10.1007/BF02976496 ↗
38. Assessment of the cytotoxicity of photocrosslinked dextran and hyaluronan-based hydrogels to vascular smooth muscle cells10.1016/S0142-9612(02)00009-1 ↗
39. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins10.1016/j.jconrel.2007.05.023 ↗
40. Characterization and degradation of functionalized chitosan with glycidyl methacrylate10.1163/1568562053700174 ↗
41. Development of photocrosslinkable hyaluronic acid-polyethylene glycol-peptide composite hydrogels for soft tissue engineering10.1002/jbm.a.30063 ↗
42. Synthesis and characterization of hydrogels formed from a glycidyl methacrylate derivative of galactomannan10.1016/j.ijpharm.2003.08.001 ↗
43. Characterization of glycosylation and adherent properties of melanoma cell lines10.1007/s00262-005-0019-4 ↗
44. A structure–function study of ligand recognition by CD22beta10.1074/jbc.M009276200 ↗
45. Degree of polymerization (DP) of polysialic acid (polySia) on neural cell adhesion molecules (N-CAMS): development and application of a new strategy to accurately determine the DP of polySia chains on N-CAMS10.1074/jbc.M508762200 ↗
46. Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells10.1016/j.bbrc.2005.12.216 ↗
47. Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells
48. Multivalent interactions at interfaces10.1016/j.cbpa.2006.09.007 ↗
49. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers10.1080/10611860600825159 ↗
50. Polyacrylamides bearing pendant alpha-sialoside groups strongly inhibit agglutination of erythrocytes by influenza A virus: multivalency and steric stabilization of particulate biological systems10.1021/jm00046a027 ↗
51. Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers10.1021/bm050672n ↗
52. Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent10.1016/j.ijpharm.2006.05.068 ↗
53. The lectin-binding properties of six generations of mannose-functionalized dendrimers10.1021/ol016568+ ↗
54. Affinity-based inhibition of beta-amyloid toxicity10.1021/bi0156254 ↗
55. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state10.1016/S0006-3495(01)75831-6 ↗
56. Peripheral treatment with Enoxaparin, a low molecular weight heparin, reduces plaques and β-Amyloid accumulation in a mouse model of Alzheimer's disease10.1523/JNEUROSCI.0550-04.2004 ↗
57. Experimental investigation of antibody-mediated clearance mechanisms of amyloid-beta in CNS of Tg-SwDI transgenic mice10.1523/JNEUROSCI.2788-07.2007 ↗